Role as of 11 Oct 2026
David A. Ricks
Chair and CEO, Eli Lilly and Company
Latest quote
Today, fewer than one in ten people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment,
We quote public statements word for word and link to where they were made. To correct or remove something, use Report a problem.